Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to 0.1%.

  • Amphastar Pharmaceuticals' Return on Invested Capital fell 600.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.15% for FY2024, which is 400.0% down from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Return on Invested Capital of 0.1% as of Q3 2025, which was down 600.0% from 0.12% recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Invested Capital ranged from a high of 0.17% in Q2 2024 and a low of 0.01% during Q1 2021
  • In the last 5 years, Amphastar Pharmaceuticals' Return on Invested Capital had a median value of 0.13% in 2022 and averaged 0.12%.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Return on Invested Capital soared by 1100bps in 2022 and then tumbled by -600bps in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.1% in 2021, then grew by 22bps to 0.13% in 2022, then grew by 21bps to 0.15% in 2023, then dropped by -5bps to 0.15% in 2024, then tumbled by -34bps to 0.1% in 2025.
  • Its Return on Invested Capital was 0.1% in Q3 2025, compared to 0.12% in Q2 2025 and 0.13% in Q1 2025.